butoctamide succinate has been researched along with Intellectual Disability in 1 studies
butoctamide succinate: increases REM sleep in chronically prepared cats; RN given refers to parent cpd; structure given in first source
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
Excerpt | Relevance | Reference |
---|---|---|
" Our findings indicate that long-term administration of BAHS at low dosage maintains its effects on REM sleep of mentally retarded children, causing modifications similar to those previously obtained with single administration at higher dosages in cats, in healthy young and elderly volunteers and in Down's syndrome children." | 2.68 | Long-term administration of butoctamide hydrogen succinate on nocturnal sleep of mentally retarded subjects: a polygraphic study versus placebo. ( Bergonzi, P; Gigli, GL; Grubar, JC; Maschio, MC, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gigli, GL | 1 |
Grubar, JC | 1 |
Bergonzi, P | 1 |
Maschio, MC | 1 |
1 trial available for butoctamide succinate and Intellectual Disability
Article | Year |
---|---|
Long-term administration of butoctamide hydrogen succinate on nocturnal sleep of mentally retarded subjects: a polygraphic study versus placebo.
Topics: Adolescent; Amides; Analysis of Variance; Child; Humans; Hydroxybutyrates; Intellectual Disability; | 1995 |